Go to Current Investments
Acusphere
(NASDAQ: ACUS)  |  www.acusphere.com

Acusphere, Inc. ™ is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microparticle technology.
AtheroGenics, Inc.
(NASDAQ: AGIX)  |  www.atherogenics.com

AtheroGenics is an emerging pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, rheumatoid arthritis and asthma.
CytoLogix, Inc.
(acquired by DakoCytomation)  |  www.dakocytomation.com

Cytologix developed the Artisan Staining System, the first instrument to provide true walk away automation for both immunohistochemical and complex special stains.
Exact Sciences, Corp.
(NASDAQ: EXAS)  |  www.exactsciences.com

EXACT Sciences is an applied genomics company with a mission to eradicate mortality from common cancers — starting with colorectal cancer — by applying advances in the field of genomics to facilitate the early detection of disease.
Insmed, Inc.
(NASDAQ: INSM)  |  www.insmed.com

Insmed Incorporated is a biopharmaceutical company focused on the development of drug candidates for the treatment of metabolicdiseases and endocrine disorderswith unmet medical needs.
NitroMed, Inc.
(NASDAQ: NTMD)  |  www.nitromed.com

NitroMed is using its expertise in nitric oxide biology and chemistry in an effort to develop both novel nitric oxide-enhancing drugs, as well as safer, more effective versions of existing drugs for major diseases that are characterized by a deficiency in nitric oxide, such as cardiovascular and inflammatory diseases.
Sequenom, Inc.
(NASDAQ: SQNM)  |  www.sequenom.com

Sequenom Genetic Systems is dedicated to the sales and support of the Company's MassARRAY hardware, consumable and software products, and the continual expansion of platform applications. The MassARRAY system is the most powerful high-performance DNA analysis platform in the industry, providing an unmatched combination of precision, throughput and simplicity.
Visualization Technology, Inc.
(NYSE: GE)  |  (acquired by GE Healthcare)  |  www.gehealthcare.com

Visualization Technology developed the InstaTrak Surgical Navigation System, an advanced technology used during Ear, Nose and Throat (ENT), Cranial and Spine procedures. Surgeons use the system to clearly visualize the patient's anatomy and the exact position of their surgical instruments within the anatomy.
Mi3 Venture Partners | One Hollis St, Suite 232 | Wellesley, MA 02482 | tel: 781-707-5050 | fax: 781-239-1541